Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BWAY - US10501L1061 - ADR

23.11 USD
+0.02 (+0.09%)
Last: 1/9/2026, 8:00:01 PM
22.7 USD
-0.41 (-1.77%)
After Hours: 1/9/2026, 8:00:01 PM
Fundamental Rating

6

BWAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. An interesting combination arises when we look at growth and value: BWAY is growing strongly while it also seems undervalued. With these ratings, BWAY could be worth investigating further for value and growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BWAY had positive earnings in the past year.
BWAY had a positive operating cash flow in the past year.
BWAY had negative earnings in 4 of the past 5 years.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

With an excellent Return On Assets value of 5.53%, BWAY belongs to the best of the industry, outperforming 82.70% of the companies in the same industry.
The Return On Equity of BWAY (8.92%) is better than 83.24% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.75%, BWAY is in the better half of the industry, outperforming 69.73% of the companies in the same industry.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BWAY has a better Profit Margin (12.73%) than 89.19% of its industry peers.
BWAY has a Operating Margin of 5.78%. This is in the better half of the industry: BWAY outperforms 70.81% of its industry peers.
BWAY has a better Gross Margin (74.92%) than 85.41% of its industry peers.
In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
Compared to 1 year ago, BWAY has more shares outstanding
Compared to 5 years ago, BWAY has more shares outstanding
Compared to 1 year ago, BWAY has a worse debt to assets ratio.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

BWAY has an Altman-Z score of 6.33. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BWAY (6.33) is better than 81.08% of its industry peers.
BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
BWAY has a better Debt to FCF ratio (0.37) than 92.43% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
The Debt to Equity ratio of BWAY (0.08) is better than 65.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 6.33
ROIC/WACC0.32
WACC8.57%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
BWAY has a Current ratio of 3.19. This is comparable to the rest of the industry: BWAY outperforms 58.92% of its industry peers.
BWAY has a Quick Ratio of 3.02. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.02, BWAY is in the better half of the industry, outperforming 66.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 260.14% over the past year.
The Revenue has grown by 27.08% in the past year. This is a very strong growth!
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%

3.2 Future

Based on estimates for the next years, BWAY will show a very strong growth in Earnings Per Share. The EPS will grow by 54.11% on average per year.
BWAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.80% yearly.
EPS Next Y68.53%
EPS Next 2Y55.05%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.60, which indicates a rather expensive current valuation of BWAY.
Based on the Price/Earnings ratio, BWAY is valued cheaper than 82.16% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.19. BWAY is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.23, BWAY is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 87.03% of the companies listed in the same industry.
BWAY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.6
Fwd PE 16.23
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

64.32% of the companies in the same industry are more expensive than BWAY, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BWAY is valued cheaply inside the industry as 84.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.65
EV/EBITDA 81.53
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 54.11% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y55.05%
EPS Next 3Y54.11%

0

5. Dividend

5.1 Amount

No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield 0%

BRAINSWAY LTD-ADR

NASDAQ:BWAY (1/9/2026, 8:00:01 PM)

After market: 22.7 -0.41 (-1.77%)

23.11

+0.02 (+0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/dmh
Earnings (Next)03-09 2026-03-09/bmo
Inst Owners4.9%
Inst Owner Change0%
Ins Owners16.11%
Ins Owner ChangeN/A
Market Cap452.05M
Revenue(TTM)49.09M
Net Income(TTM)6.25M
Analysts85.71
Price Target0.12 (-99.48%)
Short Float %0.47%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)6.71%
PT rev (3m)10.57%
EPS NQ rev (1m)-9.48%
EPS NQ rev (3m)-0.9%
EPS NY rev (1m)-3.43%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)-3.81%
Revenue NQ rev (3m)-5.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE 21.6
Fwd PE 16.23
P/S 9.21
P/FCF 24.65
P/OCF 20.3
P/B 6.45
P/tB 6.45
EV/EBITDA 81.53
EPS(TTM)1.07
EY4.63%
EPS(NY)1.42
Fwd EY6.16%
FCF(TTM)0.94
FCFY4.06%
OCF(TTM)1.14
OCFY4.93%
SpS2.51
BVpS3.58
TBVpS3.58
PEG (NY)0.32
PEG (5Y)N/A
Graham Number9.29
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 6.33
F-Score5
WACC8.57%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y68.53%
EPS Next 2Y55.05%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for BWAY stock?

The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 68.53% in the next year.